Research Progress on the Impact of HAART on Laboratory Indicators of HIV/AIDS Patients

高效抗逆转录病毒治疗(HAART)是目前治疗HIV/AIDS最为有效的方法。通过多种抗逆转录病毒药物的联合应用，HAART能够有效抑制病毒复制，从而显著改善患者的预后。然而，长期接受HAART治疗可能会对患者的多项实验室指标产生影响，包括血常规、肝功能、肾功能、血脂和血糖等。这些影响与药物种类、治疗方案、患者个体差异以及合并症等多种因素密切相关。本文还探讨了HAART不良反应的监测与应对策略，并展望了未来的研究方向。通过深入探索这些研究方向，有望进一步优化HAART治疗方案，提高HIV/AIDS患者的治疗效果和生活质量。High efficiency antiretroviral therapy (HAART) is currently the most effective method for treating HIV/AIDS. Through the combination of multiple antiretroviral drugs, HAART can effectively inhibit virus replication, thereby significantly improving the prognosis of patients. However, long-term treatment with HAART may have an impact on multiple laboratory indicators of patients, including blood routine, liver function, kidney function, blood lipids, and blood glucose. These effects are closely related to various factors such as drug types, treatment plans, individual patient differences, and comorbidities. This article also explores the monitoring and response strategies for adverse reactions of HAART, and looks forward to future research directions. By exploring these research directions in depth, it is expected to further optimize the HAART treatment plan and improve the treatment efficacy and quality of life of HIV/AIDS patients.